baber/WOPTO huggingface dataset:
Patent CA-2426726-A1 (CA)
Inventor: HORVATH STEVE
IPC: G01S13/93
Filed: 2001-10-25
Abstract: A system for graphically displaying on a cockpit display an indication of closure (i.e. a "closure indicator") with a selected target aircraft. In a preferred embodiment of the invention, the system only displays a closure indicator if: (1) the selected target aircraft is within a pre-determined monitoring zone; and (2) the track of the selected target aircraft is within a pre-determined variation angle of the track of the Own Ship aircraft. If the rate of closure between the selected target aircraft and the Own Ship aircraft is within a predetermined range of values, the closure indicator includes a closing/receding indicia (such as an upwardly or downwardly directed arrow) that indicates whether the Own Ship aircraft is closing in on or receding from the selected target aircraft. The system preferably removes the closure indicator from display when the Own Ship aircraft or the selected target aircraft ceases to be airborne.
Patent CA-2428790-A1 (CA)
Title: Spring-clip for hid lamp
Inventor: MCCULLOUGH EBON L
IPC: H01K1/50
Filed: 2003-05-12
Abstract: An assembly (10) for a lamp. The assembly 10 includes a light source (12) having a center chamber (14) and opposite ends (16, 18), arrayed along a longitudinal axis (19). The ends (16, 18) are cylindrical in cross-section. A tubular shroud (20) surrounds the light source (12) and is coaxial with the longitudinal axis (19). The light source (12) is mounted within the shroud (20) by spring clips (26) one of which is mounted at either end of the shroud. The spring clips each include a base (28) lying in a first plane and having an aperture (30), for example, a star-shaped aperture, centrally located in the base. The apertures (30) in the two spring clips frictionally engage one of the ends (16, 18) of the light source (12). Each of the spring clips (26) has a U-shaped projection (32) at and end (33) of the base (26). The U-shaped projection comprises first and second upstanding walls (34, 36) joined by a first lip (38) that extends in a second plane and is fitted over the wall of the shroud (20). One of the upstanding walls of the U-shaped projection, for example, wall (36), is formed to provide spring tension for grasping the shroud wall.
Patent CA-2430780-A1 (CA)
Title: Heart valve holder that resists suture looping
Inventor: STOBIE ROBERT
IPC: A61F2/24
Filed: 2001-12-13
Abstract: An improved holder, system and method for implanting a tissue-type prostheti c mitral heart valve that prevents suture looping and may also constrict the commissure posts of the valve. The holder may include two relatively movable  plates, one of which attaches to the valve sewing on the inflow end of the valve ring and the other which attaches via sutures or similar expedient to the valve commissures on the outflow end. Separation of the plates places th e sutures in tension and constricts the commissures. The sutures may be strand s or filaments, or may be wider bands of flexible biocompatible material. If bands are used, they desirably cover the commissure post tips to further hel p prevent suture looping thereover. The flexible lengths of material extend directly between commissures of the valve, or may extending radially inward from each commissure to a central upstanding member. Desirably, a slide is created by the flexible lengths of material adjacent each commissure post, f or example by crossing over suture filaments at or radially inward from the commissure posts. If an upstanding member is used, the lengths of suture extend axially beyond the commissure post tips to create a tent that wards o ff sutures that otherwise might loop around the tips during advancement of the valve along anarray of pre-implanted sutures.
Patent CA-2434652-A1 (CA)
Title: Type 2 cytokine receptor and nucleic acids encoding same
Inventor: DENG BIJIA
IPC: A61K39/00
Filed: 2002-01-14
Abstract: The present invention provides novel isolated CRF2-12 polynucleotides and polypeptides encoded by the CRF2-12 polynucleotides. Also provided are the antibodies that immunospecifically bind to a CRF2-12 polypeptide or any derivative (including fusion derivative), variant, mutant of the CRF2-12 polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the CRF2-12 polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states, as well as to other uses.
Patent CA-2436507-A1 (CA)
Title: Cell cultures
Inventor: MARINO FABIEN
IPC: C12N1/20
Filed: 2003-07-31
Abstract: Disclosed herein are methods, media and other compositions relating to high density cell cultures. Also disclosed are exemplary methods for using high density cell cultures and exemplary products that may be obtained from high density cell cultures.
Patent CA-2437613-A1 (CA)
Inventor: DETERING JURGEN
IPC: D06M13/35
Filed: 2002-02-05
Abstract: L'invention concerne un procédé pour doter une matière textile d'une protection UV, selon lequel on applique sur la matière textile (a) de l'oxyde de zinc ou de l'oxyde de titane en tant que constituant A et (b) un ou plusieurs absorbeurs UV organiques en tant que constituant B. Le constituant B contient de préférence un ou plusieurs composés du groupe constitué de phényl benzotriazoles, de dibenzoyl méthanes, d'esters de l'acide p-aminobenzoïque, d'esters de l'acide cinnamique, d'esters de l'acide salicylique, de 2-hydroxy benzophénones exemptes d'azote, de phényl benzimidazoles, d'acrylates, de diaryl butadiènes, d'hydroxy benzophénones aminosubstituées et de triazines.
Patent CA-2440557-A1 (CA)
Title: Combinations of heparin cofactor ii agonist and platelet iib/iiia antagonist, and uses thereof
Inventor: CARDIN ALAN D
IPC: A61K31/42
Filed: 2002-03-07
Abstract: Combined use of a heparin cofactor II agonist and a platelet GPIIb/IIIa receptor antagonist to inhibit both platelet aggregation and thrombin generation resulting from disease, injury or responses to wound repairs. The combined use of the heparin cofactor II agonist and the platelet GPIIb/IIIa receptor antagonist can achieve these therapeutic benefits while at the same time minimizing or reducing the risk of hemorrhagic side effects (e.g., prolonged bleeding), and without causing undesired antigenic responses. Moreover, certain subtherapeutic amounts of a platelet GPIIb/IIIa receptor antagonist can, in combination, be therapeutically effective in inhibiting both platelet aggregation and thrombin generation.
Patent CA-2440640-A1 (CA)
Title: Basecoat composition comprising a poly(meth)acrylate binder
Inventor: COLYER EMERSON KEITH
IPC: C08G18/62
Filed: 2002-04-26
Abstract: A refinish basecoat composition includes at least one pigment and an hydroxyl-functional acrylic polymer. The acrylic polymer has a number average molecular weight of at least about 6000 and is polymerized using at least about 45% by weight cycloaliphatic monomer, based on total monomer weight polymerized. A  mixer system that can be used to prepare the refinish basecoat has a plurality of color components, each independently including at least one pigment dispersed by the hydroxyl-functional acrylic polymer, and a pigment-free component containing the hydroxyl-functional acrylic polymer.
Patent CA-2441851-A1 (CA)
Inventor: CHENG PU-SHENG
IPC: A23L27/00
Filed: 2002-03-13
Abstract: Stabilized aroma-providing components such as chocolate, tea or coffee aroma s that are stabilized against loss or degradation of desirable flavor or senso ry characteristics of its aroma during storage. The stabilizing agent is presen t with the aroma-providing component in an amount effective to chemically interact with compounds in the aroma-providing component to: (a) provide increased amounts of desirable compounds that impart desirable flavor or sensory characteristics to the aroma; or (b) reduce the amount of undesirabl e compounds that suppress desirable flavor characteristics or that contribute to or generate undesirable flavor or sensory characteristics in the aroma. The stabilizing agent preferably is a nucleophile that contains sulfur or nitrogen, such as sulfur dioxide, sulfites, compounds or substances that contain or generate sulfites, thiols, amines or amino acids, cysteine, gluathione or an enzyme. The stabilized aroma-providing component retains th e desirable flavor and sensory characteristics of the aroma for a time period of at least six months to one year or longer.
Patent CA-2442779-A1 (CA)
Inventor: DUBE JEAN-GUY
IPC: A01K1/00
Filed: 2003-09-23
Abstract: The present invention is directed to a cooling system for agricultural buildings and, more specifically, it is directed to a support-mounted fan. The goal of this invention is to provide a fan assembly to increase the circulation of air in an agricultural building and improve the health and comfort of animals housed therein, as well as to provide for such an assembly which may be easily and conveniently positioned for such purposes.
Patent CA-2443088-A1 (CA)
Title: Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer
Inventor: SAFFRAN DOUGLAS
IPC: C12N5/06
Filed: 2002-04-09
Abstract: Published without an
Patent CA-2444611-A1 (CA)
Title: Novel insecticidal azoles
Inventor: MARTIN HANS-DIETER
IPC: A01N47/40
Filed: 2002-04-16
Abstract: The invention relates to novel heterocyclic compounds, to a method for the production of said compounds and to their use as plat protection product, especially for controlling animal pests.
Patent CA-2445404-A1 (CA)
Title: Microsensor for physiological pressure measurement
Inventor: WAVERING THOMAS
IPC: A61B5/00
Filed: 2002-04-25
Abstract: A body implantable sensor (200) for sensing pressure in an environment within internal body tissue is described. In an implementation, the sensor (200) includes a housing (310), an optical waveguide (106) and a diaphragm (206) with a reflective surface (304) that faces a waveguide distal end (302) back into the waveguide. The diaphragm (206) is movable relative to the waveguide end (302). The distance between the waveguide distal end (302) and the diaphragm reflective surface (208) is determined by pressure forces acting on a sensing surface of the diaphragm (206) and protects it from impingement, but leaves the diaphragm sensing surface (208) exposed to pressure forces. In some implementations, an attachment mechanism stabilizes the sensor (200) when implanted in the bodily tissue.
Patent CA-2446196-A1 (CA)
Inventor: PANICO LOUIS R
IPC: B29D17/00
Filed: 2002-05-06
Abstract: L'invention concerne un système de lampe à impulsions possédant au moins deux lampes (14 et 18) pour produire des impulsions avec des éléments électroniques communs (12), afin d'effectuer des traitements tels que durcissement de revêtements, durcissement d'adhésifs, gestion de l'inclinaison et initialisation du disque optique.
Patent CA-2447330-A1 (CA)
Title: Shelf stable haze free liquids of overbased alkaline earth metal salts, processes and stabilizing halogen-containing polymers therewith
Inventor: DOMINEY LAWRENCE A
IPC: C08K5/00
Filed: 2001-10-16
Abstract: Shelf stable haze free liquids of overbased alkaline earth metal salts are obtained by reacting metal base with fatty acids in the presence of liquid hydrocarbon and aliphatic alcohols having at least 8 carbon atoms to provide overbased liquids essentially free of a phenol or a phenolic derivative.  Stabilizer compositions containing the overbased liquids and mixed metal stabilizers of zinc, cadmium and tin are provided for stabilizing halogen-containing polymers.
Patent CA-2450510-A1 (CA)
Title: Cell stack for redox flow battery
Inventor: KANNO TAKASHI
IPC: H01M6/48
Filed: 2002-05-07
Abstract: This invention provides a cell stack for a redox flow battery that can provide battery efficiencies with high reliability over a long term, without any adhesive bonding between a bipolar plate and electrodes. In the cell stack 1 for the redox flow battery of a cell frame 2, electrodes 3, 4 and a membrane 5 being stacked in layers, the cell frame 2 comprises a frame 2A and a bipolar plate 9 arranged inside of the frame 2A, and the electrodes 3, 4 are put into close contact with the bipolar plate 9 by a clamping force, without being adhesively bonded to the bipolar plate 9. It is preferable that when the electrodes 3, 4 are compressed to a thickness corresponding to a level difference between the frame 2A and the bipolar plate 9, repulsive force of the electrodes is in the range of more than 15kPa to less than 150kPa (more than 0.153kgf/cm2 to less than 1.53kgf/cm2).
Patent CA-2450795-A1 (CA)
Inventor: HALLENBECK ROBERT F
IPC: C07K1/18
Filed: 1996-06-07
Abstract: A method of modifying protein solubility employs polyionic polymers. These facilitate the solubilization, formulation, purification and refolding of proteins especially incorrectly folded proteins and aggregated proteins. Compositions are described that are suitable for formulating TFPI. The compositions allow preparation of pharmaceutically acceptable compositions of TFPI at concentrations above 0.2 mg/mL and above 10 mg/mL.
Patent CA-2452460-A1 (CA)
Title: System and method for controlling user interface features of a web application
Inventor: BOWMAN GORDON
IPC: G06F3/00
Filed: 2003-12-08
Abstract: A system and method of controlling user interface features of a web application is provided. The system comprises a collection of user interface control elements, a collection of skin templates comprising extensible markup language based markup contained as children of a container element, and a collection of control element instructions for performing actions associated with the control elements. Ea ch control element comprises a namespace, common attributes for defining graphical features of the control element and for associating the control element with the internal state of the core control element, other attributes for defining attributes that affect the intrinsic behavior of the control, and a skin template reference attribute for referencing a skin template. Each instruction is associated with a control element.
Patent CA-2452611-A1 (CA)
Inventor: ROSE BJOERN
IPC: D21C3/02
Filed: 2002-07-01
Abstract: L'invention concerne un procédé de délignification de matières premières lignocellulosiques, par l'utilisation de sulfites en présence d'un constituant alcalin, en particulier de l'hydroxyde de sodium ou du carbonate de sodium ou encore un mélange de ces derniers, dans une solution aqueuse à une température et une pression accrues. Ce procédé se caractérise en ce qu'une première partie du constituant alcalin est ajoutée au début d'une dissolution et au moins une deuxième partie du constituant alcalin est ajoutée à la solution aqueuse au plut tôt, au début de la délignification.
Patent CA-2453119-A1 (CA)
Inventor: AMERGA MESSAY
IPC: H04B1/7117
Filed: 2002-07-12
Abstract: A method for assigning tracking elements includes sorting a list of potential assignments according to a diversity criterion. In one example, a list of received signal instances is sorted first according to a measure of energy and then sorted again according to the diversity criterion. In a further embodiment, a demodulation element may be labeled available for assignment yet continue to output demodulated symbols in a locked state. Applications to a mobile station of a CDMA system for cellular telephony are discussed.
Patent CA-2454306-A1 (CA)
Inventor: LAHM GEORGE PHILIP
IPC: C07D231/16
Filed: 2002-08-13
Abstract: L'invention concerne un composé de formule (I) ainsi que son procédé de préparation et d'utilisation dans la préparation d'un composé de formule (II). Dans ces formules, R?1¿, R?2¿, R?3¿, X et n sont tels que définis dans la description. L'invention concerne également la préparation de composés de formule (III), dans laquelle R?1¿, R?2¿, R?6¿, R?7¿, R?8¿ et n sont tels que définis dans la description. L'invention se rapporte en outre à des produits intermédiaires de formule (4) pour la préparation de composés de formule (I). Dans la formule (4), X est N et R?2¿, R?3¿ et n sont tels que définis dans la description.
Patent CA-2454341-A1 (CA)
Title: Plasma protein matrices and methods for their preparation
Inventor: GLICKLIS RACHEL
IPC: A61L27/00
Filed: 2002-07-18
Abstract: A freeze dried biocompatible matrix comprising plasma proteins, useful as implants for tissue engineering as well as in biotechnology, and methods of producing said matrix are provided. Mechanical and physical parameters can be controlled by use of auxiliary components or additives which may be removed after the matrix is formed in order to improve the biological properties of the matrix. The matrices according to the present invention may be used clinically, per se or as a cell-bearing implant.
Patent CA-2455425-A1 (CA)
Inventor: KUO KOU-WHA
IPC: C07J71/00
Filed: 2004-01-20
Abstract: A water soluble extract from a plant of Solanum genus consists essentially of at least 60%-90% of solamargine and solasonine. A process for preparing the water soluble extract from the plant of Solanum genus involves the steps of hydrolysis with an acid, precipitation with a base, and separation treatments using chloroform, alcohol and water as extraction solvents. The water soluble extract prepared from the process can be directly dissolved in pure or neutral pH water to form a yellowish clear and transparent aqueous solution having a water solubility ranging from 2~20 mg/ml or higher. The water soluble extract can be used as an active component in a pharmaceutical composition for inhibiting the growth of tumor/cancer cells, in particular liver cancer cells, lung cancer cells and breast cancer cells.
Patent CA-2457237-A1 (CA)
Title: System and method for collision-free transmission scheduling using neighborhood information and advertised transmission times
Inventor: GARCIA-LUNA-ACEVES JOSE J
IPC: H04L45/122
Filed: 2002-08-26
Abstract: The present invention provides a medium access control (MAC) protocol for the collision-free transmission of packets into a channel, such that nodes are assigned time slots for collision-free transmission based on the knowledge they acquire regarding the constituency of their local neighborhoods and the advertisements of the time slots when nodes in local neighborhoods will attempt to transmit again. The scheduling procedure may utilize an age of the network together with the unique identifiers of nodes. The candidate transmission times for each node are determined using a list of the subsequent transmission times advertised by other nodes. The nodes discards the advertised transmission times from the list of potential transmission times, and computes its candidate transmission times using a function that provides a varying (psuedorandom) distribution of outputs for a varying sample of inputs.  This function may be a hash function, an encryption function, or a table-lookup function. The computation of candidate transmission times uses the identifiers of those nodes for which no advertised transmission time has been obtained.
Patent CA-2458235-A1 (CA)
Title: Intestine dysfunction treatment apparatus
Inventor: FORSELL PETER
IPC: A61N1/08
Filed: 2002-06-24
Abstract: An intestine dysfunction treatment apparatus comprises an electric stimulation device (56) implanted in a patient, who suffers from intestine dysfunction.  The stimulation device is adapted to directly engage with a muscle that directly or indirectly affects the transportation of the content of the patient's intestines, for example the anal sphincter (58) or a portion of the muscle that contracts the bowels. A control device (62) is operable by the patient to control the stimulation device to stimulate the muscle to increase the tonus thereof. The apparatus can be used for treating patients suffering from anal incontinence or constipation.
Patent CA-2460433-A1 (CA)
Title: Low permeation nylon tube with aluminium barrier layer
Inventor: DUKE JEREMY
IPC: B32B15/088
Filed: 2002-09-12
Abstract: A fuel transport tube having improved fuel vapor permeation characteristics comprising an inner conductive nylon tubular structure (12, 22), an aluminum barrier layer (14, 24) on the outside surface of the nylon inner tubular layer, and a non-conductive nylon layer (16, 26) on the outer surface of the aluminum layer; and a method for making the fuel transport tube are disclosed.
Patent CA-2461818-A1 (CA)
Inventor: STEWART TIMOTHY A
IPC: G01N33/567
Filed: 2002-10-15
Abstract: On administre, dans le cadre de cette invention, des protéines de Dickkopf-5 (Dkk-5), sous des quantités efficaces, pour traiter des pathologies se traduisant par une résistance à l'insuline, notamment le diabète sucré non insulino-dépendant (DNID) ou l'obésité. L'invention a également trait à une méthode permettant de diagnostiquer une résistance à l'insuline ainsi que des troubles en rapports et ce, à l'aide de Dkk-5 comme outil de mesure. Elle concerne, de surcroît, des nécessaires diagnostiques et thérapeutiques. Elle porte, en outre, sur des hybridomes destinés à produire des anticorps anti Dkk-5 ainsi que sur des préparations contenant les protéines Dkk-5.
Patent CA-2464157-A1 (CA)
Inventor: KRAEMER ROLF H
IPC: B23B27/10
Filed: 2002-10-07
Abstract: Fluid passageway (36''') are defined by the top plate (30), tool holder body (22) and the cutting insert (27) to permit the optimum cooling of the interface between the insert and the word piece reducing degradation of the cutting edge of the insert. A number of top plate designs with channel configurations are disclosed to provide the desired coolant flow distributio n and accommodate the desired flow rate.
Patent CA-2469114-A1 (CA)
Inventor: TANAKA DON
IPC: A61M16/04
Filed: 2004-05-28
Abstract: A long term oxygen therapy system having an oxygen supply directly linked with a patient's lung or lungs may be utilized to more efficiently treat hypoxia caused by chronic obstructive pulmonary disease such as emphysema and chronic bronchitis. The system includes an oxygen source, one or more valves and fluid carrying conduits. The fluid carrying conduits link the oxygen source to diseased sites within the patient's lungs. A collateral ventilation bypass trap system directly linked with a patient's lung or lungs may be utilized to increase the expiratory flow from the diseased lung or lungs, thereby treating another aspect of chronic obstructive pulmonary disease. The system includes a trap, a filter/one-way valve and an air carrying conduit. In various embodiments, the system may be intrathoracic, extrathoracic or a combination thereof. A pulmonary decompression device may also be utilized to remove trapped air in the lung or lungs, thereby reducing the volume of diseased lung tissue. In order for the system to be effective, an airtight seal between the parietal and visceral pleurae is required. Chemical pleurodesis is utilized for creating the seal.
Patent CA-2470546-A1 (CA)
Title: Method and apparatus for providing carrier synchronization in digital broadcast and interactive systems
Inventor: LEE LIN-NAN
IPC: H04L27/00
Filed: 2004-06-09
Abstract: An approach is provided for supporting carrier synchronization in a digital broadcast and interactive system (100). A carrier synchronization module (302) receives one or more signals representing a frame that includes one or more overhead fields (e.g., preamble and optional pilot blocks and one or multiple segments separated by pilot blocks).  The module (302) estimates carrier frequency and phase on a segment by segment basis and tracks frequency-between segments. Carrier phase of the signal is estimated based upon the overhead field. Estimates earner phase of random data field are determined based upon the estimated phase values from the overhead fields, and upon both the past and future data signals. Further, the frequency of the signal is estimated based upon the overhead fields and/or the random data field. The above arrangement is particularly suited to a digital satellite broadcast and interactive system (100).